Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

NEW YORK, June 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

http://www.reportlinker.com/p02063528/Smoking-Cessation-and-Nicotine-De-addiction-Products-Market-Nicotine-Gums-Patches-Lozenges-Inhalers-Sprays-Sublingual-Tablets-Zyban-Chantix/Champix-E-cigarettes---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW).

Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 List of Abbreviations
1.3.4 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Global Smoking Cessation and Nicotine De-addiction Market Overview
3.1 Market Definition and Overview
3.1.1 Nicotine Consumption, Prevalence And Trends
3.1.2 Smoking Health Hazards
3.2 R&D Pipeline
3.3 Combination Therapy for Smoking Cessation/Nicotine De-addiction
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy
3.4.1.2 Government intervention for smoking de-addiction
3.4.1.3 Introduction of new products will expand the market
3.4.1.4 Reimbursement for smoking cessation therapy
3.4.2 Restraints
3.4.2.1 Low awareness about smoking cessation products in the developing economies
3.4.2.2 Legal obligations dragging growth of several smoking cessation product segments
3.4.3 Opportunities
3.4.3.1 Research and Development
3.4.3.2 Market Expansion
3.5 Porter's Five Forces Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market
3.5.1 Bargaining Power Of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from New Entrants
3.5.4 Threat from Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography

Chapter 4 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type
4.1 Introduction
4.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 - 2019 (USD Million)
4.2 Nicotine Replacement Therapy Products
4.2.1 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
4.2.1 Nicotine Gums
4.2.1.1 Global Nicotine Gums Market Revenue, 2011 - 2019 (USD Million)
4.2.2 Nicotine Transdermal Patches
4.2.2.1 Global Nicotine Transdermal Patches Market Revenue, 2011 - 2019 (USD Million)
4.2.3 Nicotine Lozenges
4.2.3.1 Global Nicotine Lozenges Market Revenue, 2011 - 2019 (USD Million)
4.2.4 Nicotine Sprays
4.2.4.1 Global Nicotine Sprays Market Revenue, 2011 - 2019 (USD Million)
4.3 Nicotine Inhalers
4.3.1 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
4.4 Nicotine Sublingual Tablets
4.4.1 Global Nicotine Sublingual Tablets Market Revenue, 2011 - 2019 (USD Million)
4.5 Electronic Cigarettes (E-cigarettes)
4.5.1 Global E-cigarettes Market Revenue, 2011 - 2019 (USD Million)
4.6 Drug Therapy
4.6.1 Global Drug Therapy Market for Smoking Cessation, 2011 - 2019 (USD Million)
4.6.2 Zyban (Bupropion)
4.6.3 Global Zyban Market Revenue, by Geography, 2011 – 2019 (USD Million)
4.6.3.1 Global Zyban Market Revenue, 2011 - 2019 (USD Million)
4.6.4 Chantix/Champix (varenicline)
4.6.5 Global Champix/Chantix Market Revenue, by Geography, 2011 – 2019 (USD Million)
4.6.5.1 Global Chantix/Champix Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
5.1 Introduction
5.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)
5.2 North America
5.2.1 North America Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.2.2 North America Smoking Cessation and Nicotine De-addiction Products Market, 2011 – 2019 (USD Million)
5.3 Europe
5.3.1 Europe Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.3.2 European Smoking Cessation and Nicotine De-addiction Products, Market revenue, by Geography, 2011 – 2019 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.4.2 Asia-Pacific Smoking Cessation and Nicotine De-addiction Products Market, 2011 – 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
5.5.2 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Heat Map Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market
6.1.1 Methodology
6.1.2 Heat Map Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market, by key players, 2012

Chapter 7 Recommendations
7.1 Investment In Private Label Brands
7.2 Asia-Pacific Offering Various Opportunities to Smoking Cessation Market
7.3 Diversification to Electronic Cigarettes Business
7.4 Expansion Through Mergers and Acquisitions

Chapter 8 Company Profiles
8.1 Cipla Ltd.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Development
8.2 GlaxoSmithKline, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Imperial Tobacco Company of India (ITC Ltd).
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Development
8.4 McNeil AB
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.5 NJOY, Inc.
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Business Strategies
8.5.4 Recent Development
8.6 Novartis International AG
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Pfizer, Inc.

8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategy
8.7.5 Recent Development
8.8 Revolymer PLC
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Development
8.9 Takeda Pharmaceutical Co. Ltd.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Development
8.10 VMR Products LLC
8.10.1 Company Profile
8.10.2 Product Portfolio
8.10.3 Business Strategies

List of Figures

FIG. 1 Global Smoking Cessation and Nicotine De-addiction Products Market – Market Segmentation
FIG. 1 Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, 2010-2019 (USD Million)
FIG. 2 Porter's Five Forces Analysis for Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012
FIG. 3 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012
FIG. 4 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
FIG. 5 Global Nicotine Gums Market Revenue, 2011 – 2019 (USD Million)
FIG. 6 Global Nicotine Transdermal Patched Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Nicotine Lozenges Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Nicotine Sprays Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
FIG. 10 Global Nicotine Sublingual Tablets Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global E-cigarettes Market Revenue, 2011-2019 (USD Million)

FIG. 12 Global Zyban Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Chantix/ Champix Market Revenue, 2011- 2019 (USD Million)
FIG. 14 Comparative Analysis : Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2012 and 2019 (USD million)
FIG. 15 North America Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 European Smoking Cessation and Nicotine De-addiction Products, Market Revenue, by Geography, 2011 – 2019 (USD Million)
FIG. 17 Asia-Pacific Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Rest of the World Smoking Cessation and Nicotine De-addiction Products, Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Heat Map Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Key Players (2012)
FIG. 20 Cipla Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 GlaxoSmithKline Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 ITC Ltd., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Johnson & Johnson Consumer Segment**, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Novartis International AG, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Pfizer Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 Revolymer PLC., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Takeda Pharmaceutical Co. Ltd., Annual Revenue: 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Smoking Cessation and Nicotine De-addiction Products Market
TABLE 2 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Types, 2011 - 2019 (USD Million)
TABLE 3 Global Zyban Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 4 Global Champix/Chantix Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 5 Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography, 2011 – 2019 (USD Million)
TABLE 6 North America Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 7 Europe Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 8 Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)
TABLE 9 Rest of the World Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 – 2019 (USD Million)

To order this report: Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
http://www.reportlinker.com/p02063528/Smoking-Cessation-and-Nicotine-De-addiction-Products-Market-Nicotine-Gums-Patches-Lozenges-Inhalers-Sprays-Sublingual-Tablets-Zyban-Chantix/Champix-E-cigarettes---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast-2013---2019.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker